ELI LILLY AND COMPANY Other Comprehensive Income (Loss), Net of Tax
ELI LILLY AND COMPANY (LLY) reported Other Comprehensive Income (Loss), Net of Tax of $103.70 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2024-10-30
- ELI LILLY AND COMPANY other comprehensive income (loss), net of tax for the quarter ending 2024-09-30 was $103.70M, a 2628.95% increase year-over-year.
- ELI LILLY AND COMPANY other comprehensive income (loss), net of tax for the quarter ending 2024-06-30 was -$79.00M.
- ELI LILLY AND COMPANY other comprehensive income (loss), net of tax for the quarter ending 2024-03-31 was $27.50M, a 59.14% decline year-over-year.
- ELI LILLY AND COMPANY other comprehensive income (loss), net of tax for the quarter ending 2023-09-30 was $3.80M.
- ELI LILLY AND COMPANY other comprehensive income (loss), net of tax for fiscal 2022 was $498.50M, a 76.85% decline from fiscal 2021.
- ELI LILLY AND COMPANY other comprehensive income (loss), net of tax for fiscal 2021 was $2.15B, a 7816.54% increase from fiscal 2020.
- ELI LILLY AND COMPANY other comprehensive income (loss), net of tax for fiscal 2020 was $27.20M.
- ELI LILLY AND COMPANY other comprehensive income (loss), net of tax for fiscal 2019 was -$783.40M, a 1037.08% decline from fiscal 2018.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2024-09-30 | $103.70M 10-Q · filed 2024-10-30 | $24.70M derived: sum of 2 quarters · filed 2024-10-30 | $52.20M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | -$79.00M 10-Q · filed 2024-08-08 | -$51.50M 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $27.50M 10-Q · filed 2024-04-30 | |||
| 2023-09-30 | $3.80M 10-Q · filed 2024-10-30 | -$7.60M derived: sum of 2 quarters · filed 2024-10-30 | $59.70M 10-Q · filed 2024-10-30 | $510.90M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | -$11.40M 10-Q · filed 2024-08-08 | $55.90M 10-Q · filed 2024-08-08 | $507.10M derived: sum of 3 quarters · filed 2024-08-08 | $499.00M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $67.30M 10-Q · filed 2024-04-30 | $518.50M derived: sum of 2 quarters · filed 2024-04-30 | $510.40M derived: sum of 3 quarters · filed 2024-04-30 | $448.00M derived: sum of 4 quarters · filed 2024-04-30 |
| 2022-12-31 | $451.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $443.10M derived: sum of 2 quarters · filed 2023-11-02 | $380.70M derived: sum of 3 quarters · filed 2023-11-02 | $498.50M 10-K · filed 2023-02-22 |
| 2022-09-30 | -$8.10M 10-Q · filed 2023-11-02 | -$70.50M derived: sum of 2 quarters · filed 2023-11-02 | $47.30M 10-Q · filed 2023-11-02 | $1.88B derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$62.40M 10-Q · filed 2023-08-08 | $55.40M 10-Q · filed 2023-08-08 | $1.89B derived: sum of 3 quarters · filed 2023-08-08 | $2.00B derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $117.80M 10-Q · filed 2023-04-27 | $1.95B derived: sum of 2 quarters · filed 2023-04-27 | $2.06B derived: sum of 3 quarters · filed 2023-04-27 | $2.17B derived: sum of 4 quarters · filed 2023-04-27 |
| 2021-12-31 | $1.83B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.94B derived: sum of 2 quarters · filed 2023-02-22 | $2.05B derived: sum of 3 quarters · filed 2023-02-22 | $2.15B 10-K · filed 2023-02-22 |
| 2021-09-30 | $114.40M 10-Q · filed 2022-11-01 | $222.90M derived: sum of 2 quarters · filed 2022-11-01 | $323.70M 10-Q · filed 2022-11-01 | $382.40M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $108.50M 10-Q · filed 2022-08-04 | $209.30M 10-Q · filed 2022-08-04 | $268.00M derived: sum of 3 quarters · filed 2023-02-22 | $395.80M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $100.80M 10-Q · filed 2022-04-29 | $159.50M derived: sum of 2 quarters · filed 2023-02-22 | $287.30M derived: sum of 3 quarters · filed 2023-02-22 | $490.30M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $58.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $186.50M derived: sum of 2 quarters · filed 2023-02-22 | $389.50M derived: sum of 3 quarters · filed 2023-02-22 | $27.20M 10-K · filed 2023-02-22 |
| 2020-09-30 | $127.80M 10-Q · filed 2021-10-27 | $330.80M derived: sum of 2 quarters · filed 2021-10-27 | -$31.50M 10-Q · filed 2021-10-27 | -$820.60M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $203.00M 10-Q · filed 2021-08-03 | -$159.30M 10-Q · filed 2021-08-03 | -$948.40M derived: sum of 3 quarters · filed 2022-02-23 | -$1.08B derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | -$362.30M 10-Q · filed 2021-04-30 | -$1.15B derived: sum of 2 quarters · filed 2022-02-23 | -$1.29B derived: sum of 3 quarters · filed 2022-02-23 | -$1.20B derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | -$789.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$923.10M derived: sum of 2 quarters · filed 2022-02-23 | -$836.10M derived: sum of 3 quarters · filed 2022-02-23 | -$783.40M 10-K · filed 2022-02-23 |
| 2019-09-30 | -$134.00M 10-Q · filed 2020-10-28 | -$47.00M derived: sum of 2 quarters · filed 2020-10-28 | $5.70M 10-Q · filed 2020-10-28 | -$286.00M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $87.00M 10-Q · filed 2020-07-31 | $139.70M 10-Q · filed 2020-07-31 | -$152.00M derived: sum of 3 quarters · filed 2021-02-17 | $508.20M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $52.70M 10-Q · filed 2020-05-01 | -$239.00M derived: sum of 2 quarters · filed 2021-02-17 | $421.20M derived: sum of 3 quarters · filed 2021-02-17 | -$250.00M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | -$291.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $368.50M derived: sum of 2 quarters · filed 2021-02-17 | -$302.70M derived: sum of 3 quarters · filed 2021-02-17 | $83.60M 10-K · filed 2021-02-17 |
| 2018-09-30 | $660.20M 10-Q · filed 2019-10-25 | -$11.00M derived: sum of 2 quarters · filed 2019-10-25 | $375.30M 10-Q · filed 2019-10-25 | -$101.40M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | -$671.20M 10-Q · filed 2019-08-02 | -$284.90M 10-Q · filed 2019-08-02 | -$761.60M derived: sum of 3 quarters · filed 2020-02-19 | -$593.90M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $386.30M 10-Q · filed 2019-05-02 | -$90.40M derived: sum of 2 quarters · filed 2020-02-19 | $77.30M derived: sum of 3 quarters · filed 2020-02-19 | $362.10M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | -$476.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$309.00M derived: sum of 2 quarters · filed 2020-02-19 | -$24.20M derived: sum of 3 quarters · filed 2020-02-19 | $174.50M 10-K · filed 2020-02-19 |
| 2017-09-30 | $167.70M 10-Q · filed 2018-11-06 | $452.50M derived: sum of 2 quarters · filed 2018-11-06 | $651.20M 10-Q · filed 2018-11-06 | -$316.90M derived: sum of 4 quarters · filed 2019-10-24 |
| 2017-06-30 | $284.80M 10-Q · filed 2018-07-25 | $483.50M 10-Q · filed 2018-07-25 | -$484.60M derived: sum of 3 quarters · filed 2019-10-24 | -$371.10M derived: sum of 4 quarters · filed 2019-10-24 |
| 2017-03-31 | $198.70M 10-Q · filed 2018-04-27 | -$769.40M derived: sum of 2 quarters · filed 2019-10-24 | -$655.90M derived: sum of 3 quarters · filed 2019-10-24 | -$762.40M derived: sum of 4 quarters · filed 2019-10-24 |
| 2016-12-31 | -$968.10M derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24 | -$854.60M derived: sum of 2 quarters · filed 2019-10-24 | -$961.10M derived: sum of 3 quarters · filed 2019-10-24 | -$645.10M 8-K · filed 2019-10-24 |
| 2016-09-30 | $113.50M 10-Q · filed 2017-10-27 | $7.00M derived: sum of 2 quarters · filed 2017-10-27 | $323.00M 10-Q · filed 2017-10-27 | $409.30M derived: sum of 4 quarters · filed 2018-02-20 |
| 2016-06-30 | -$106.50M 10-Q · filed 2017-07-28 | $209.50M 10-Q · filed 2017-07-28 | $295.80M derived: sum of 3 quarters · filed 2018-02-20 | $32.00M derived: sum of 4 quarters · filed 2018-02-20 |
| 2016-03-31 | $316.00M 10-Q · filed 2017-05-01 | $402.30M derived: sum of 2 quarters · filed 2018-02-20 | $138.50M derived: sum of 3 quarters · filed 2018-02-20 | $392.80M derived: sum of 4 quarters · filed 2018-02-20 |
| 2015-12-31 | $86.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | -$177.50M derived: sum of 2 quarters · filed 2018-02-20 | $76.80M derived: sum of 3 quarters · filed 2018-02-20 | -$588.90M 10-K · filed 2018-02-20 |
| 2015-09-30 | -$263.80M 10-Q · filed 2016-10-28 | -$9.50M derived: sum of 2 quarters · filed 2016-10-28 | -$675.20M 10-Q · filed 2016-10-28 | -$2.12B derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | $254.30M 10-Q · filed 2016-07-28 | -$411.40M 10-Q · filed 2016-07-28 | -$1.85B derived: sum of 3 quarters · filed 2017-02-21 | -$2.47B derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | -$665.70M 10-Q · filed 2016-04-29 | -$2.11B derived: sum of 2 quarters · filed 2017-02-21 | -$2.72B derived: sum of 3 quarters · filed 2017-02-21 | -$2.70B derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | -$1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | -$2.06B derived: sum of 2 quarters · filed 2017-02-21 | -$2.03B derived: sum of 3 quarters · filed 2017-02-21 | -$1.99B 10-K · filed 2017-02-21 |
| 2014-09-30 | -$616.30M 10-Q · filed 2015-10-30 | -$594.30M derived: sum of 2 quarters · filed 2015-10-30 | -$548.90M 10-Q · filed 2015-10-30 | $1.01B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $22.00M 10-Q · filed 2015-07-30 | $67.40M 10-Q · filed 2015-07-30 | $1.63B derived: sum of 3 quarters · filed 2016-02-19 | $2.01B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $45.40M 10-Q · filed 2015-04-30 | $1.61B derived: sum of 2 quarters · filed 2016-02-19 | $1.99B derived: sum of 3 quarters · filed 2016-02-19 | $2.06B derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $1.56B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $1.95B derived: sum of 2 quarters · filed 2016-02-19 | $2.01B derived: sum of 3 quarters · filed 2016-02-19 | $1.79B 10-K · filed 2016-02-19 |
| 2013-09-30 | $384.60M 10-Q · filed 2014-10-29 | $450.30M derived: sum of 2 quarters · filed 2014-10-29 | $233.00M 10-Q · filed 2014-10-29 | -$28.20M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $65.70M 10-Q · filed 2014-07-28 | -$151.60M 10-Q · filed 2014-07-28 | -$412.80M derived: sum of 3 quarters · filed 2015-02-19 | -$14.50M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | -$217.30M 10-Q · filed 2014-04-28 | -$478.50M derived: sum of 2 quarters · filed 2015-02-19 | -$80.20M derived: sum of 3 quarters · filed 2015-02-19 | -$465.20M derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | -$261.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $137.10M derived: sum of 2 quarters · filed 2015-02-19 | -$247.90M derived: sum of 3 quarters · filed 2015-02-19 | $61.50M 10-K · filed 2015-02-19 |
| 2012-09-30 | $398.30M 10-Q · filed 2013-10-30 | $13.30M derived: sum of 2 quarters · filed 2013-10-30 | $322.70M 10-Q · filed 2013-10-30 | -$1.03B derived: sum of 4 quarters · filed 2014-02-19 |
| 2012-06-30 | -$385.00M 10-Q · filed 2013-07-26 | -$75.60M 10-Q · filed 2013-07-26 | -$1.43B derived: sum of 3 quarters · filed 2014-02-19 | -$1.92B derived: sum of 4 quarters · filed 2014-02-19 |
| 2012-03-31 | $309.40M 10-Q · filed 2013-04-26 | -$1.04B derived: sum of 2 quarters · filed 2014-02-19 | -$1.54B derived: sum of 3 quarters · filed 2014-02-19 | -$1.36B derived: sum of 4 quarters · filed 2014-02-19 |
| 2011-12-31 | -$1.35B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19 | -$1.85B derived: sum of 2 quarters · filed 2014-02-19 | -$1.67B derived: sum of 3 quarters · filed 2014-02-19 | -$1.19B 10-K · filed 2014-02-19 |
| 2011-09-30 | -$496.00M 10-Q · filed 2012-10-26 | -$317.10M derived: sum of 2 quarters · filed 2012-10-26 | $164.20M 10-Q · filed 2012-10-26 | |
| 2011-06-30 | $178.90M 10-Q · filed 2012-07-27 | $660.20M 10-Q · filed 2012-07-27 | ||
| 2011-03-31 | $481.30M 10-Q · filed 2012-04-30 | |||
| 2010-12-31 | -$198.20M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |